Biomerica Inc (BMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 05/31
| 11-2020 | 08-2020 | 05-2020 | 02-2020 | 11-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,611 | -1,892 | -2,677 | -1,853 | -992 |
| Depreciation Amortization | 180 | 90 | 399 | 308 | 223 |
| Accounts receivable | -256 | -19 | -309 | 489 | 168 |
| Other Working Capital | -371 | -248 | -2,573 | 540 | 357 |
| Other Operating Activity | 1,178 | 472 | 863 | -287 | -123 |
| Operating Cash Flow | $-2,880 | $-1,597 | $-4,298 | $-803 | $-366 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -62 | -40 | -34 | -28 | -6 |
| Purchase Sale Intangibles | -62 | -53 | -85 | -24 | -15 |
| Other Investing Activity | -62 | -53 | -85 | -24 | -15 |
| Investing Cash Flow | $-123 | $-93 | $-119 | $-52 | $-21 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 49 | 15 | 10,456 | 646 | 557 |
| Other Financing Activity | 0 | 0 | 1,918 | 1,918 | 0 |
| Financing Cash Flow | $49 | $15 | $12,374 | $2,564 | $557 |
| Exchange Rate Effect | -3 | -2 | -3 | -4 | -5 |
| Beginning Cash Position | 8,641 | 8,641 | 687 | 687 | 687 |
| End Cash Position | 5,684 | 6,964 | 8,641 | 2,392 | 851 |
| Net Cash Flow | $-2,957 | $-1,677 | $7,954 | $1,705 | $164 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,880 | -1,597 | -4,298 | -803 | -366 |
| Capital Expenditure | -62 | -40 | -34 | -28 | -6 |
| Free Cash Flow | -2,942 | -1,637 | -4,331 | -831 | -372 |